Showing results (21-30 of 258) with videos related to
Sort By:
Pageof 26
The Journal of Clinical Endocrinology and Metabolism|February 5, 2020
Ten Years of Very Infrequent Zoledronate Therapy in Older Women: An Open-Label Extension of a Randomized TrialAndrew Grey, Anne Horne, Greg Gamble, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 26, 2010
Prolonged antiresorptive activity of zoledronate: a randomized, controlled trialAndrew Grey, Mark Bolland, Diana Wattie, et al.The American Journal of Clinical Nutrition|July 25, 2014
Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysisJohn A Ford, Graeme S MacLennan, Alison Avenell, et al.European Journal of Endocrinology|March 13, 2012
Pioglitazone increases bone marrow fat in type 2 diabetes: results from a randomized controlled trialAndrew Grey, Vaughan Beckley, Anthony Doyle, et al.Addiction (Abingdon, England)|October 20, 2010
Decreased bone density in men on methadone maintenance therapyAndrew Grey, Karla Rix-Trott, Anne Horne, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 14, 2013
Duration of antiresorptive effects of low-dose zoledronate in osteopenic postmenopausal women: a randomized, placebo-controlled trialAndrew Grey, Mark Bolland, Bobby Mihov, et al.The Journal of Clinical Endocrinology and Metabolism|February 1, 2007
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trialAndrew Grey, Mark Bolland, Greg Gamble, et al.Pageof 26